Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Feb 13, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways of providing therapy to help people who have had a stroke regain the use of their arms and hands. One method is the traditional "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE), which takes place in a clinic, while the other method involves the same therapy delivered at home. The researchers want to see if doing the therapy at home is just as effective and how follow-up sessions after two weeks of therapy might help improve patients’ abilities to perform daily activities and participate in social situations.
To be eligible for this study, participants need to be adults who have had a stroke for more than six months and can follow simple instructions. They should be able to move their arms and hold objects with their affected hand. It's also important for them to have a caregiver available to help for about 6.5 hours each day during the two weeks of therapy. Participants won't be able to join if they have uncontrolled seizures, have had certain treatments or surgeries recently, or have severe vision or thinking problems that might interfere with the therapy. If eligible, participants can expect to receive intensive therapy aimed at improving their arm and hand function while being closely monitored by healthcare professionals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with a chronic stroke (older than 6 months)
- • Ability to interact and understand simple instructions in order to complete assessments and therapy
- • Ability to perform a partial shoulder flexion or abduction, a partial elbow extension, and hold an object in the paretic hand
- • Availability of a caregiver for 6h30 per day during two weeks of therapy
- Exclusion Criteria:
- • Non controlled seizure
- • Botulinum toxin injection in the last 6 months before the first assessment or during the therapy
- • Intensive therapy in the last 6 months before the first assessment or during the therapy
- • Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy
- • Severe visual or cognitive impairments interfering with treatment and or assessments
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussel, , Belgium
Patients applied
Trial Officials
Yannick Bleyenheuft, Phd, Prof.
Principal Investigator
Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials